Pfizer Goodwill and Intangible Assets 2010-2024 | PFE

Pfizer goodwill and intangible assets for the quarter ending December 31, 2024 were $123.938B, a 4.43% decline year-over-year.

  • Pfizer goodwill and intangible assets for 2024 were $123.938B, a 0% decline from 2024.
  • Pfizer goodwill and intangible assets for 2024 were $123.938B, a 6.59% decline from 2023.
  • Pfizer goodwill and intangible assets for 2023 were $132.683B, a 0% decline from 2023.

Pfizer Goodwill and Intangible Assets 2010-2024 | PFE

  • Pfizer goodwill and intangible assets for 2024 were $123.938B, a 0% decline from 2024.
  • Pfizer goodwill and intangible assets for 2024 were $123.938B, a 6.59% decline from 2023.
  • Pfizer goodwill and intangible assets for 2023 were $132.683B, a 0% decline from 2023.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B